Supplementary Data from Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy

Supplemental data include a Supplemental Table-1, Supplemental Figure 1, Supplemental Figure 2, Supplemental Figure 3, Supplemental Figure 4, Supplemental Figure 5 and Supplemental Figure 6. Supplemental Table-1 is related to Figure 1 Supplemental Figure 1 is related to Figure 2 Supplemental Figure 2 is related to Figure 5 Supplemental Figures 3-5 are related to Figure 6 Supplemental Figure 6 is related to Figure 1 and Figure 5